Asociación entre variables ecográficas de adiposidad abdominal y variables analíticas y antropométricas aplicando análisis de correlación canónica en gestantes normopeso / Association between echography variables of abdominal adiposity and analytical and anthropometric variables applying canonical correlation analysis in normal-weight pregnant

RESUMEN Fundamento: La obesidad abdominal en gestantes es un marcador de riesgo cardiometabólico independientemente de la adiposidad general, siendo la ultrasonografía de gran utilidad para distinguir los compartimientos adiposos del abdomen y diagnosticar tal peligro al inicio de la gestación. Objetivo: Determinar asociaciones entre variables ecográficas de adiposidad abdominal y variables analíticas y antropométricas en gestantes normopeso al inicio del embarazo según fenotipos metabólicos empleando análisis de correlación canónica. Metodología: Estudio transversal en 526 embarazadas normopeso, entre 12 y 14 semanas de edad gestacional, atendidas en consulta de ultrasonido del Policlínico Docente Chiqui Gómez, municipio Santa Clara. Se midieron las grasas abdominales subcutánea, preperitoneal y visceral, así como variables antropométricas y analíticas. Se conformaron 3 fenotipos metabólicos, y se aplicó la correlación canónica para determinar el nexo entre las mismas y su comportamiento en los diferentes fenotipos. Resultados: Se identificaron 2 conjuntos de variables con correlaciones canónicas que se incrementaron del fenotipo saludable al metabólicamente obeso con valores de 0.6930 a 0.8955 y 0.9298 respectivamente y alta significancia estadística (p=0.000). Conclusiones: Se demuestra el nexo entre las variables ecográficas de adiposidad abdominal grasa subcutánea y grasa visceral y las variables analíticas resistencia a Ia insulina, producto de acumulación lipídico, índice aterogénico y glucemia, evidenciado por los altos valores de correlaciones canónicas obtenidos según cambia el fenotipo de normopeso saludable al metabólicamente obeso; orientando un nuevo enfoque en la determinación de fenotipos de riesgo metabólico en la gestación temprana en mujeres normopeso.

ABSTRACT Background: Abdominal obesity in pregnant women is an indicator of cardiometabolic risk with non-independence of general adiposity, being the ultrasound very useful to distinguish the abdomen adipose compartments also diagnose this risk at the beginning of pregnancy. Objective: To determine possible associations between the ultrasound variables of abdominal adiposity and those analytical and anthropometric in normal-weight pregnant women at the beginning of pregnancy according to metabolic phenotypes using canonical correlation analysis. Methodology: A cross-sectional study in 526 normal-weight pregnant women, between 12 and 14 weeks of gestational age, assisted in the ultrasound office at Chiqui Gómez teaching polyclinic, in Santa Clara city. Subcutaneous, preperitoneal and visceral abdominal fats were measured, as well as anthropometric and analytical variables. Three metabolic phenotypes were formed, and canonical correlation was applied to determine their relation and also behavior among the different phenotypes. Results: 2 sets of variables were identified with canonical correlations that increased from the healthy to the metabolically obese phenotype with values from 0.6930 to 0.8955 and 0.9298 respectively and high statistical significance (p=0.000). Conclusions: The link between the ultrasound variables of abdominal adiposity, subcutaneous and visceral fat and the analytical insulin resistance, lipid accumulation product, atherogenic index and blood glucose is demonstrated, evidenced by the high values of canonical correlations obtained as the phenotype changes from healthy normal-weight to metabolically obese; guiding a new approach in the resolve of the metabolic risk phenotypes in early gestation in normal-weight women.

Asociación entre el espesor de la grasa subcutánea abdominal y la esteatosis hepática, las enzimas hepáticas y los lípidos séricos en niños obesos / Association of abdominal subcutaneous fat thickness with hepatic steatosis, liver enzymes, and serum lipids in obese children

Introducción. La obesidad infantil puede causar hiperlipidemia y esteatosis hepática y complicaciones crónicas. Nuestro objetivo fue evaluar la relación entre el espesor de la grasa subcutánea abdominal (GSA) y la esteatosis hepática, las transaminasas y los lípidos séricos en niños obesos.Población y métodos. Estudio retrospectivo en niños (4-18 años) que acudieron a los consultorios externos. Se evaluaron las asociaciones entre el espesor de la GSA mediante ecografía y la esteatosis hepática, alanina aminotransferasa (ALT), aspartato aminotransferasa (AST) y el perfil lipídico sérico.Resultados. Se identificaron 95 niños con esteatosis hepática; el grado 1 fue el más frecuente (73,6 %, n: 70), seguido del grado 2 (21,1 %) y del 3 (5,3 %). El espesor medio (en mm) de la GSA de línea media y flancos fue 38,48 ± 11,53 y 20,91 ± 8,00 en grado 1; 41,23 ± 10,03 y 19,84 ± 6,75 en grado 2, y 63,12 ± 12,08 y 23,22 ± 5,92 en grado 3, respectivamente. El espesor de la GSA de línea media y flancos se correlacionó positivamente con triglicéridos en grado 3; el espesor de la GSA de línea media se correlacionó con el índice de masa corporal, colesterol total, colesterol LDL y AST (r: 0,9; p: 0,037; r: 0,648; p: 0,001; r: 0,387; p: 0,001; r: 0,406; p: 0,001; r: 0,463; p: 0,001; respectivamente) en grado 1.Conclusión. El espesor de la GSA mediante ecografía puede predecir hiperlipidemia en niños obesos con esteatosis hepática de grado 3 e hipercolesterolemia en grado 1.

Introduction. Childhood obesity can cause hyperlipidemia and hepatic steatosis at early age and chronic disease complications in adult life. We aimed to evaluate the relationship between abdominal subcutaneous fat thickness (ASFT) and hepatic steatosis, serum lipid and transaminase levels in obese children.Population and methods. A retrospective study was conducted with children (aged 4-18 years) who presented to outpatient clinic due to obesity. Associations between ASFT as assessed by ultrasonography (US) and hepatic steatosis, alanine transaminase (ALT), aspartate transaminase (AST) and serum lipid profile were evaluated.Results. We identified 95 children, all of which were diagnosed as having hepatic steatosis; the most common type was grade 1 (73.6 %, n: 70), followed by grade 2 (21.1 %) and grade 3 (5.3 %). The mean values of midline and flank ASFT were measured as 38.48 ± 11.53 mm and 20.91 ± 8.00 mm in grade 1; 41.23 ± 10.03 and 19.84 ± 6.75 in grade 2 and 63.12 ± 12.08 and 23.22 ± 5.92 in grade 3 hepatic steatosis, respectively. Midline and flank ASFT correlated positively with triglycerides in grade 3 steatosis, while midline ASFT correlated with body mass index, total cholesterol, low-density lipoprotein cholesterol, and AST (r: 0.9; p: 0.037; r: 0.648, p: 0.001; r: 0.387, p: 0.001; r: 0.406, p: 0.001, r: 0.463, p: 0.001; respectively) in grade 1 steatosis.Conclusion. ASFT as assessed by US may be of predictive value for hyperlipidemia in grade 3 and for hypercholesterolemia in grade 1 hepatic steatosis in obese children.

Efficacy and safety of noninvasive focused ultrasound for treatment of subcutaneous adiposity in healthy women.

INTRODUCTION: In recent years, a new method focused ultrasound (FUS) has been used in the treatment of localized fat. The objectives of this work were to evaluate the efficacy and safety of the FUS in the treatment of abdominal subcutaneous fat. MATERIALS AND METHODS: Thirty-one healthy women were divided into two groups: G1 (N = 7), 6 sessions, 3 passes, once a week and G2 (N = 23), 10 sessions, 2 passes, twice a week. Outcome measures were reduction of circumference and fat thickness. Safety monitoring included laboratory testing (serum lipids profile and liver function tests) and adverse events were also assessed. Patient satisfaction and tolerance questionnaires were also applied. One patient underwent abdominoplasty and received a single session of FUS 24 h before surgery and a skin sample was collected for histological analysis. RESULTS: The results showed improvement in body contouring and reduction of the thickness of the fat layer observed by ultrasonography in both groups: G1 (P < 0.001) and G2 (P < 0.0001). The histology showed disrupted adipocytes and collapsed membranes 24 h after the FUS treatment. CONCLUSION: FUS represents an effective and safe treatment for reducing localized adipose tissue by adipocytolysis.

Immediate effect and safety of HIFU single treatment for male subcutaneous fat reduction.

BACKGROUND: The increasing search for procedures for fat reduction is related to dissatisfaction with body shape. High-intensity focused ultrasound (HIFU) has been proven effective in body sculpting when used noninvasively to reduce subcutaneous fat and improve body contour. AIMS: This study aimed to evaluate the immediate effect and safety of HIFU single treatment for male localized fat and body remodeling. PATIENTS/METHODS: Twenty-four male subjects (18 to 59 years old) with BMI ≤ 30 kg/cm² and at least 2 cm of abdominal fat received a single HIFU treatment session. Individuals were subjected to abdominal measurements before and after procedure. In addition, biochemical analyses of blood samples were performed to assess possible inflammatory effects or oxidative stress induction by the treatment. RESULTS: High-intensity focused ultrasound was found to be an effective treatment in reducing localized adiposities in the abdominal region. A significant decrease (0.6%) was observed in infraumbilical circumference of subjects submitted to HIFU single treatment when compared with control subjects. The laboratory parameters did not present any appreciable changes. CONCLUSION: This study further strengthens the current view that HIFU is an effective and safe tool for localized fat reduction.

Analysis of subcutaneous and visceral fat after gastric balloon treatment.

BACKGROUND AND OBJECTIVES: This project is a continuation of a larger project entitled "Treatment with intragastric balloon (IGB) in patients with overweight and obesity in Recife" developed by Professor Dr. Gustavo Lopes de Carvalho. It is a project studying the effectiveness of treatment with IGB evaluating the loss of weight and body mass index and its impact on blood pressure, blood glucose, triglycerides, total cholesterol and fractions. It also assesses the lifestyle of patients studying whether treatment with IGB interferes in smoking, alcohol consumption, eating habits and physical exercises performed by patients. The present study added a larger project, the separate evaluation of the different types of abdominal fat-visceral fat and subcutaneous cell tissue fat - and was conducted to discover which of the 2 types of fat undergoes the greater reduction after IGB treatment. To measure these 2 types of fat, we used the ultrasonography technique, because it has been shown to be accurate and noninvasive. METHODS: Twenty-five patients were evaluated before and after 6 months of IGB treatment. RESULTS: The patients' ages ranged from 20 to 61 years, with 60% being 40 years of age or older. The majority (72%) were women. All variables (weight, body mass index [BMI], VF, and SCTF) showed a significant reduction (P < .05) in mean values after treatment. The difference was highest in the SCTF (17.5%) and ranged from an 11.4% to an 11.6% reduction in all other variables. The average loss of SCTF was highest among the patients who had lost up to 10.0% of their initial weight (19.2% for the ≤10.0% group vs 15.9% for the >10.0% group); however, the difference was not significant (P = .66). The average loss of VF was higher in the subgroup of patients who had lost >10.0% of their initial weight (16.2% vs 6.3%; P = .003). The Pearson correlation between the reductions in SCTF vs VF was negative, low, and nonsignificant (-0.17; P = .41). CONCLUSIONS: After 6 months of IGB treatment, there was no significant difference between the reduction in abdominal SCTF and VF, but the results signify a possible correlation between the percentage of body weight loss and the type of abdominal fat reduced, as the impact on the VF was higher when the patients lost >10.0% of their initial weight.

Waist circumference in children and adolescents correlate with metabolic syndrome and fat deposits in young adults.

BACKGROUND & AIMS: To determine the relevance of waist circumference (WC) measurement and monitoring in children and adolescents as an early indicator of overweight, metabolic syndrome (MS) and cardiovascular problems in young adults in comparison with visceral and subcutaneous adiposity. METHODS: A cohort study with 159 subjects (51.6% female) started in 1999 with an average age of 13.2 years. In 1999, 2006 and 2008 weight, height, and WC were evaluated. In 2006 blood samples for laboratory diagnosis of MS were added. In 2008 abdominal computed tomography (ACT) to quantify the fat deposits were also added. RESULTS: The WC measured in children and adolescents was strongly correlated with body mass index (BMI) measured simultaneously. A strong correlation was established between WC in 1999 with measures of WC and BMI as young adults. WC strongly correlated with fat deposits in ACT. The WC in 1999 expressed more subcutaneous fat (SAT), while the WC when young adults expressed strong correlation with both visceral fat (VAT) and SAT. The correlation of WC with fat deposits was stronger in females. WC and not BMI in 1999 was significantly higher in the group that evolved to MS. CONCLUSIONS: The WC in children and adolescents was useful in screening patients for MS. WC expressed the accumulation of abdominal fat; especially subcutaneous fat.